LUCENCE HEALTH INC.

History

Year	Detail
2016	The company Lucence Health Inc. was founded in California, U.S.
2017	It has raised USD 9.2 Mn in seed funding and received a Clinical Laboratory License in Singapore.
2018	Lucence Health Inc. launched its flagship test, Liquid HALLMARK.
2019	The company has raised USD 20 Mn in Series A led by IHH healthcare and in the same year Singapore Laboratory received federal CLIA license, California out-of-state license and CAP accreditation.
2020	Compan's Palo Alto Lab received a California state license and a federal CLIA license.
2021	Palo Alto Lab received CAP accreditation and Launched a multicenter prospective study in the U.S. and Singapore.
2022	Lucence Health Inc. expanded US LiquidHALLMARK profiling to include both ctDNA and ctRNA.
2023	US Medicare coverage achieved for Liquid HALLMARK.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment